Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial): study protocol for a randomised controlled trial

Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial): study protocol for a randomised controlled trial

Abstract Background Sarcopenia (the age-related loss of muscle mass and function) is a major contributor to loss of mobility, falls, loss of independence, morbidity and mortality in older people. Although resistance training is effective in preventing and reversing sarcopenia, many older people are...

Full description

Bibliographic Details
Main Authors: Margaret M. Band, Deepa Sumukadas, Allan D. Struthers, Alison Avenell, Peter T. Donnan, Paul R. Kemp, Karen T. Smith, Cheryl L. Hume, Adrian Hapca, Miles D. Witham
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Trials
Subjects:
Older people
Perindopril
Leucine
Sarcopenia
Physical function
Quality of life
Online Access:http://link.springer.com/article/10.1186/s13063-017-2390-9

Internet

http://link.springer.com/article/10.1186/s13063-017-2390-9

Similar Items